BEZ235 Trial in Patients With Advanced Endometrial Carcinoma
Status:
Withdrawn
Trial end date:
2017-12-01
Target enrollment:
Participant gender:
Summary
This is an open label and single arm study to investigate the safety and efficacy of BEZ235
in adult women with endometrial carcinoma whose disease progressed (or recurred) while on or
after first-line antineoplastic treatment for advanced endometrial carcinoma.